(Q37856779)

24 August 2017

1 reference

title

Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function (English)

1 reference

24 August 2017

0 references

1 reference

3

1 reference

24 August 2017

Shuko Takeda

1

1 reference

24 August 2017

Naoyuki Sato

series ordinal

2

1 reference

24 August 2017

Ryuichi Morishita

series ordinal

4

1 reference

24 August 2017

publication date

24 March 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

7

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

1822-1827

1 reference

Obesity wars: molecular progress confronts an expanding epidemic

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Abdominal obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Metabolic links between diabetes and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Association of diabetes mellitus and dementia: the Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Strategies for disease modification in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Polypeptide composition of paired helical filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Inhibition and modulation of gamma-secretase for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Targeting beta-amyloid pathology in Alzheimer's disease with Abeta immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Does insulin dysfunction play a role in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Neurovascular regulation in the normal brain and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Neurovascular mechanisms of Alzheimer's neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Glycogen synthase kinase 3: more than a namesake

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

mTOR-dependent signalling in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Regulation of insulin receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Molecular connexions between dementia and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Diabetes, obesity, and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

New perspectives into the molecular pathogenesis and treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Mitogen-activated protein kinases in synaptic plasticity and memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Targeting the CREB pathway for memory enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

CREB and the discovery of cognitive enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Functions of PI 3-kinase in development of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Restraining PI3K: mTOR signalling goes back to the membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Role for neuronal insulin resistance in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00302F

21 January 2018

Identifiers

DOI

10.1039/C0MB00302F

1 reference

24 August 2017

1 reference